MedTrace Logo

Prospective Post-Market Data Collection on Patients With Knee OA and Treated With nSTRIDE APS

NCT02580643 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2020-06-11

No results posted yet for this study

Summary

This study will document treatment effects, changes in quality of life, procedure complications, adverse events, healthcare resource utilization, and further needed intervention(s) following treatment with nSTRIDE autologous protein solution. This study will also allow for the documentation of the same parameters following multiple injections of autologous protein solution to treat knee osteoarthritis.

Conditions

  • Osteoarthritis, Knee

Interventions

BIOLOGICAL

APS

intra-articular injection

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02580643 on ClinicalTrials.gov